Statistics for Cardiff Oncology, (id:5729 CRDF)

Valuation metrics

Market cap

131.92M

Enterprise value

75.94M

Trailing P/E (ttm)

-2.63

Forward P/E

-2.55

PEG ratio

-2.55

Price/Sales (ttm)

191.75

Price/Book (mrq)

2.54

Enterprise Value/Revenue

110.38

Enterprise Value/EBITDA

-1.65

Overview

Shares outstanding

51.13M

Float

47.76M

Shares short

8.07M

% Held by insiders

0.07%

% Held by institutions

0.26%

Average volume (10 days)

1.31M

Average volume (90 days)

Price summary

52-Week low

1.15

52-Week high

6.42

52-Week change

50.20%

Beta

1.93

50-Day moving average

2.82

200-Day moving average

3.08

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

February 20th, 2019

Ex-dividend date

Last split factor

2:1

Last split date

February 20th, 2019

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-7,636.97%

Operational effectiveness

Return on assets

-38.33%

Return on equity

-67.57%

Income statement

Revenue (ttm)

0.02

Revenue per share (ttm)

0.02

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-46,000,000.00

Net income to common (ttm)

-43,005,000.00

Diluted EPS (ttm)

-0.95

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

57.67M

Total cash per share (mrq)

1.13

Total debt (mrq)

1.69M

Total Debt/Equity (mrq)

3.41

Current ratio (mrq)

473.70%

Book value per share (mrq)

1.01

Cash flow

Cash flow statement

-34,565,000.00

Levered free cash flow (LFCF)

-19,853,876.00